$TYRA

$21.52 +$1.10 (5.39%) Close

$TYRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 59.7M shares outstanding

Who owns TYRA?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 142.3%

Rajeev Shah 23.7% · Peter Kolchinsky 23.7%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

166

+2 vs last qtr

Net shares bought

+3.3M

by institutions in Q2 2026

New / sold out

31 / 29

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jupiter Topco LLC NEW +4.4M
Price T Rowe Associates Inc /MD/ +1.8M

Biggest sellers in Q2 2026

Janus Henderson Group PLC SOLD OUT −3.9M
Farallon Capital Management, L.L.C. SOLD OUT −3.6M

Who is planning to sell?

Notices of proposed sale, last 12 months

$33.1M

15 notices from 4 people

Shares covered

1.2M

2.07% of the company

Arranged in advance

91%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Nextech Vi Oncology SCSP Shareholder 10b5-1 $19.6M
Daniel Bensen Officer $5.62M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+332.5%

+44.21% a year

Each share's claim on the business

−76.9%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $77.8M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years54% 1–3 years26% Under 1 year21%

Quarterly turnover

23.8%

of institutional shares changed hands

Top 10 managers, median time held

4.5 years

Super Investors

Investment managers reporting TYRA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
RC Ra Capital Management, L.P. 13D · 19.9%	12.2M	20.44%	Unchanged	2021	3.4%
Shares held by quarter Peak holding12.2M (Q2'25) Change over 8 quarters+1.8M Share of the company20.440% Disclosed stake13D · 19.9% Ra Capital Management, L.P.'s full portfolio →
F FMR LLC	8.9M	14.95%	+1.2M (+15.1%)	2021	0.0%
Shares held by quarter Peak holding8.9M (Q2'26) Change over 8 quarters+5.5M Share of the company14.950% FMR LLC's full portfolio →

Ra Capital Management, L.P.

13D · 19.9%

12.2M

% of company

20.44%

Change vs last qtr

Unchanged

Held since

2021

FMR LLC

8.9M

% of company

14.95%

Change vs last qtr

+1.2M (+15.1%)

Held since

2021

28 more super investors behind a free account

See every manager holding Tyra Biosciences, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting TYRA on Form N-PORT; together they hold 33.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FO Fidelity OTC Portfolio Fidelity Securities Fund	$105M	3.3M	5.52%	0.24%	July 31, 2026
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$44.5M	1.4M	2.33%	0.41%	June 30, 2026

Fidelity OTC Portfolio

Fidelity Securities Fund

Position value

$105M

% of company

5.52%

% of the fund

0.24%

As of

July 31, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$44.5M

% of company

2.33%

% of the fund

0.41%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Tyra Biosciences, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
RS Rajeev Shah 5%+ holder 13D · 19.9%	14.1M	23.68%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company23.680% Disclosed stake13D · 19.9% View the 13D/G filing →
PK Peter Kolchinsky 5%+ holder 13D · 19.9%	14.1M	23.68%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company23.680% Disclosed stake13D · 19.9% View the 13D/G filing →

Rajeev Shah

5%+ holder13D · 19.9%

14.1M

% of company

23.68%

Change vs last qtr

—

Held since

—

Peter Kolchinsky

5%+ holder13D · 19.9%

14.1M

% of company

23.68%

Change vs last qtr

—

Held since

—

12 more holders behind a free account

See every insider and 5%+ holder of Tyra Biosciences, Inc..

Comments